Asia Pacific Organoids Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific Organoids Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Organoids Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific Organoids Market Regional Analysis

6.2 Asia Pacific Organoids Market Revenue 2021-2031 (US$ Million)

6.3 Asia Pacific Organoids Market Forecast Analysis

7. Asia Pacific Organoids Market Analysis – by Type

7.1 Intestine

7.1.1 Overview
7.1.2 Intestine: Asia Pacific Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Liver

7.2.1 Overview
7.2.2 Liver: Asia Pacific Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Stomach

7.3.1 Overview
7.3.2 Stomach: Asia Pacific Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Pancreas

7.4.1 Overview
7.4.2 Pancreas: Asia Pacific Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.5 Lung

7.5.1 Overview
7.5.2 Lung: Asia Pacific Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.6 Brain

7.6.1 Overview
7.6.2 Brain: Asia Pacific Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.7 Kidney

7.7.1 Overview
7.7.2 Kidney: Asia Pacific Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.8 Others

7.8.1 Overview
7.8.2 Others : Asia Pacific Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Organoids Market Analysis – by Application

8.1 Developmental Biology Disease

8.1.1 Overview
8.1.2 Developmental Biology Disease: Asia Pacific Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Pathology of Infectious Disease

8.2.1 Overview
8.2.2 Pathology of Infectious Disease: Asia Pacific Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Regenerative Medicine

8.3.1 Overview
8.3.2 Regenerative Medicine: Asia Pacific Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.4 Drug Toxicity and Efficacy Testing

8.4.1 Overview
8.4.2 Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.5 Drug Discovery and Personalized Medicine

8.5.1 Overview
8.5.2 Drug Discovery and Personalized Medicine: Asia Pacific Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.6 Others

8.6.1 Overview
8.6.2 Others: Asia Pacific Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Organoids Market Analysis – by Source

9.1 Pluripotent Stem Cells

9.1.1 Overview
9.1.2 Pluripotent Stem Cells: Asia Pacific Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.2 Organ-Specific Adult Stem Cell

9.2.1 Overview
9.2.2 Organ-Specific Adult Stem Cell: Asia Pacific Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. Asia Pacific Organoids Market Analysis – by Offering

10.1 Instruments

10.1.1 Overview
10.1.2 Instruments: Asia Pacific Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.2 Consumables

10.2.1 Overview
10.2.2 Consumables: Asia Pacific Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.3 Services

10.3.1 Overview
10.3.2 Services: Asia Pacific Organoids Market – Revenue and Forecast, 2021-2031 (US$ Million)

11. Asia Pacific Organoids Market – Asia Pacific Analysis

11.1 Overview

11.2 Asia Pacific

11.2.1 Asia Pacific Organoids Market Breakdown, by Key Country, 2024 and 2031 (%)
11.2.1.1 Asia Pacific Organoids Market – Revenue and Forecast Analysis – by Country
11.2.1.1 Japan: Asia Pacific Organoids Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.1.1 Japan: Asia Pacific Organoids Market Breakdown, by Type
11.2.1.1.2 Japan: Asia Pacific Organoids Market Breakdown, by Application
11.2.1.1.3 Japan: Asia Pacific Organoids Market Breakdown, by Source
11.2.1.1.4 Japan: Asia Pacific Organoids Market Breakdown, by Offering

11.2.1.2 China: Asia Pacific Organoids Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.2.1 China: Asia Pacific Organoids Market Breakdown, by Type
11.2.1.2.2 China: Asia Pacific Organoids Market Breakdown, by Application
11.2.1.2.3 China: Asia Pacific Organoids Market Breakdown, by Source
11.2.1.2.4 China: Asia Pacific Organoids Market Breakdown, by Offering

11.2.1.3 India: Asia Pacific Organoids Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.3.1 India: Asia Pacific Organoids Market Breakdown, by Type
11.2.1.3.2 India: Asia Pacific Organoids Market Breakdown, by Application
11.2.1.3.3 India: Asia Pacific Organoids Market Breakdown, by Source
11.2.1.3.4 India: Asia Pacific Organoids Market Breakdown, by Offering

11.2.1.4 South Korea: Asia Pacific Organoids Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.4.1 South Korea: Asia Pacific Organoids Market Breakdown, by Type
11.2.1.4.2 South Korea: Asia Pacific Organoids Market Breakdown, by Application
11.2.1.4.3 South Korea: Asia Pacific Organoids Market Breakdown, by Source
11.2.1.4.4 South Korea: Asia Pacific Organoids Market Breakdown, by Offering

11.2.1.5 Australia: Asia Pacific Organoids Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.5.1 Australia: Asia Pacific Organoids Market Breakdown, by Type
11.2.1.5.2 Australia: Asia Pacific Organoids Market Breakdown, by Application
11.2.1.5.3 Australia: Asia Pacific Organoids Market Breakdown, by Source
11.2.1.5.4 Australia: Asia Pacific Organoids Market Breakdown, by Offering

11.2.1.6 SouTheast Asia: Asia Pacific Organoids Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.6.1 SouTheast Asia: Asia Pacific Organoids Market Breakdown, by Type
11.2.1.6.2 SouTheast Asia: Asia Pacific Organoids Market Breakdown, by Application
11.2.1.6.3 SouTheast Asia: Asia Pacific Organoids Market Breakdown, by Source
11.2.1.6.4 SouTheast Asia: Asia Pacific Organoids Market Breakdown, by Offering

11.2.1.7 Rest of Asia Pacific: Asia Pacific Organoids Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.7.1 Rest of Asia Pacific: Asia Pacific Organoids Market Breakdown, by Type
11.2.1.7.2 Rest of Asia Pacific: Asia Pacific Organoids Market Breakdown, by Application
11.2.1.7.3 Rest of Asia Pacific: Asia Pacific Organoids Market Breakdown, by Source
11.2.1.7.4 Rest of Asia Pacific: Asia Pacific Organoids Market Breakdown, by Offering

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 STEMCELL Technologies Inc

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Molecular Devices, LLC.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Hubrecht Organoid Technology

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Definigen

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Organoid Therapeutics

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Thermo Fisher Scientific Inc

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Corning Inc

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Merck KGaA

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 InSphero

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 ACRO Biosystems

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

14.11 Bio-Techne Corp

14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments

14.12 SUN bioscience SA

14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments

14.13 ORGANOID SCIENCES Co., Ltd.

14.13.1 Key Facts
14.13.2 Business Description
14.13.3 Products and Services
14.13.4 Financial Overview
14.13.5 SWOT Analysis
14.13.6 Key Developments

14.14 Crown Bioscience Inc

14.14.1 Key Facts
14.14.2 Business Description
14.14.3 Products and Services
14.14.4 Financial Overview
14.14.5 SWOT Analysis
14.14.6 Key Developments

14.15 Sartorius AG

14.15.1 Key Facts
14.15.2 Business Description
14.15.3 Products and Services
14.15.4 Financial Overview
14.15.5 SWOT Analysis
14.15.6 Key Developments

14.16 3D Biotek LLC

14.16.1 Key Facts
14.16.2 Business Description
14.16.3 Products and Services
14.16.4 Financial Overview
14.16.5 SWOT Analysis
14.16.6 Key Developments

14.17 Prellis Biologics Inc.

14.17.1 Key Facts
14.17.2 Business Description
14.17.3 Products and Services
14.17.4 Financial Overview
14.17.5 SWOT Analysis
14.17.6 Key Developments

14.18 3Dnamics Inc.

14.18.1 Key Facts
14.18.2 Business Description
14.18.3 Products and Services
14.18.4 Financial Overview
14.18.5 SWOT Analysis
14.18.6 Key Developments

14.19 Cellesce Ltd

14.19.1 Key Facts
14.19.2 Business Description
14.19.3 Products and Services
14.19.4 Financial Overview
14.19.5 SWOT Analysis
14.19.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Asia Pacific Organoids Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis